288 related articles for article (PubMed ID: 11739273)
21. C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells.
Lin R; Liu J; Gan W; Yang G
Biol Pharm Bull; 2004 Oct; 27(10):1537-43. PubMed ID: 15467191
[TBL] [Abstract][Full Text] [Related]
22. Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis.
Fuentes L; Hernández M; Fernández-Avilés FJ; Crespo MS; Nieto ML
Circ Res; 2002 Oct; 91(8):681-8. PubMed ID: 12386144
[TBL] [Abstract][Full Text] [Related]
23. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
[TBL] [Abstract][Full Text] [Related]
24. CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis.
Laman JD; De Boer M; Hart BA
Dev Immunol; 1998; 6(3-4):215-22. PubMed ID: 9814595
[TBL] [Abstract][Full Text] [Related]
25. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
[TBL] [Abstract][Full Text] [Related]
26. CD40-CD40L interactions in atherosclerosis.
Lutgens E; Daemen MJ
Trends Cardiovasc Med; 2002 Jan; 12(1):27-32. PubMed ID: 11796241
[TBL] [Abstract][Full Text] [Related]
27. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
28. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice.
Willecke F; Tiwari S; Rupprecht B; Wolf D; Hergeth S; Hoppe N; Dufner B; Schulte L; Anto Michel N; Bukosza N; Marchini T; Jäckel M; Stachon P; Hilgendorf I; Zeschky K; Schleicher R; Langer HF; von Zur Muhlen C; Bode C; Peter K; Zirlik A
Thromb Haemost; 2014 Aug; 112(2):379-89. PubMed ID: 24652469
[TBL] [Abstract][Full Text] [Related]
29. CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells.
Greene JA; Portillo JA; Lopez Corcino Y; Subauste CS
PLoS One; 2015; 10(12):e0144133. PubMed ID: 26710229
[TBL] [Abstract][Full Text] [Related]
30. Ligation of CD40 onvascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity.
Horton DB; Libby P; Schonbeck U
Ann N Y Acad Sci; 2001 Dec; 947():329-36. PubMed ID: 11795284
[TBL] [Abstract][Full Text] [Related]
31. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
[TBL] [Abstract][Full Text] [Related]
32. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
Leroyer AS; Rautou PE; Silvestre JS; Castier Y; Lesèche G; Devue C; Duriez M; Brandes RP; Lutgens E; Tedgui A; Boulanger CM
J Am Coll Cardiol; 2008 Oct; 52(16):1302-11. PubMed ID: 18929241
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40.
Suo Z; Tan J; Placzek A; Crawford F; Fang C; Mullan M
Brain Res; 1998 Oct; 807(1-2):110-7. PubMed ID: 9757011
[TBL] [Abstract][Full Text] [Related]
34. The CD40/CD40L system: a new therapeutic target for disease.
Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R
Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087
[TBL] [Abstract][Full Text] [Related]
35. CD40-40L signaling in vascular inflammation.
Chakrabarti S; Blair P; Freedman JE
J Biol Chem; 2007 Jun; 282(25):18307-18317. PubMed ID: 17459878
[TBL] [Abstract][Full Text] [Related]
36. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
Pietrella D; Lupo P; Perito S; Mosci P; Bistoni F; Vecchiarelli A
FEMS Immunol Med Microbiol; 2004 Jan; 40(1):63-70. PubMed ID: 14734188
[TBL] [Abstract][Full Text] [Related]
37. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.
Gerdes N; Sukhova GK; Libby P; Reynolds RS; Young JL; Schönbeck U
J Exp Med; 2002 Jan; 195(2):245-57. PubMed ID: 11805151
[TBL] [Abstract][Full Text] [Related]
38. CD40 and its ligand in atherosclerosis.
Lutgens E; Lievens D; Beckers L; Donners M; Daemen M
Trends Cardiovasc Med; 2007 May; 17(4):118-23. PubMed ID: 17482093
[TBL] [Abstract][Full Text] [Related]
39. CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide.
Netea MG; Meer JW; Verschueren I; Kullberg BJ
Eur J Immunol; 2002 May; 32(5):1455-63. PubMed ID: 11981834
[TBL] [Abstract][Full Text] [Related]
40. CD154 (CD40 ligand).
Schönbeck U; Mach F; Libby P
Int J Biochem Cell Biol; 2000 Jul; 32(7):687-93. PubMed ID: 10856699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
